Compass Pathways Plc ADR (CMPS)

$2.66 -0.10 (-3.62%)
Market Cap 258.23M
Revenue (ttm) 0.00
Net Income (ttm) -155.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.16
Volume 4,348,500
Avg Vol 2,399,866
Day's Range N/A - N/A
Shares Out 93.56M
Stochastic %K 14%
Beta 2.25
Analysts Strong Sell
Price Target $16.40

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities
Sector: Healthcare
Address:
33 Broadwick Street, London, United Kingdom
diodor
diodor Jun. 27 at 9:18 AM
$CMPS
0 · Reply
No_one_important_in_here
No_one_important_in_here Jun. 27 at 12:27 AM
$ALT what is it with bios presenting what looks like good data and they get cut in half? Same thing happened to $CMPS. Market must hate good news lately 😏
2 · Reply
No_one_important_in_here
No_one_important_in_here Jun. 26 at 9:15 PM
$CMPS soon...
0 · Reply
cacci11
cacci11 Jun. 26 at 7:51 PM
$CMPS after hours pump incoming
2 · Reply
Bulltrader988
Bulltrader988 Jun. 26 at 7:12 PM
$MNMD added this basket today $CMPS $CYBN $MIRA 👃👀
0 · Reply
InvestorNOR
InvestorNOR Jun. 26 at 6:19 PM
$CMPS $3 is imminent 🙏
0 · Reply
dboyer_32
dboyer_32 Jun. 26 at 5:08 PM
$CMPS
0 · Reply
SlayQueenOfCalls
SlayQueenOfCalls Jun. 26 at 4:59 PM
$CMPS 🎵🎵 don’t shroom me like that, don’t shroom me like that, what if I love you baby? Don’t shroom me like that. 🎶🎶
1 · Reply
cacci11
cacci11 Jun. 26 at 4:52 PM
$CMPS lame duck volume by comparison, but still movement. Price action is depressing, but shorts die hard
1 · Reply
No_one_important_in_here
No_one_important_in_here Jun. 26 at 4:44 PM
$CMPS this shade of green isnt what i like. Give us the shade of green that we had yesterday :)
0 · Reply
Latest News on CMPS
Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Jun 24, 2025, 2:47 PM EDT - 2 days ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jun 23, 2025, 8:25 AM EDT - 3 days ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 8:12 AM EDT - 3 days ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:48 AM EDT - 4 days ago

Compass Pathways' depression drug succeeds late-stage trial

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Jun 23, 2025, 6:30 AM EDT - 4 days ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 14, 2025, 6:30 AM EDT - 6 weeks ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:14 AM EDT - 7 weeks ago

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 6:30 AM EDT - 7 weeks ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 29, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 28, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Apr 22, 2025, 6:00 AM EDT - 2 months ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

This Is a Test From GlobeNewswire

Mar 28, 2025, 5:01 PM EDT - 3 months ago

This Is a Test From GlobeNewswire

ALVO

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 26, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in Stifel Virtual CNS Forum

Mar 11, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Feb 28, 2025, 5:08 PM EST - 4 months ago

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 4:02 PM EST - 4 months ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:41 AM EST - 4 months ago

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 27, 2025, 6:30 AM EST - 4 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 25, 2025, 4:00 PM EST - 4 months ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 18, 2025, 6:30 AM EST - 4 months ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 6:30 AM EST - 5 months ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 21, 2025, 6:30 AM EST - 5 months ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Compass Pathways Announces Pricing of Underwritten Offering

Jan 10, 2025, 7:01 AM EST - 5 months ago

Compass Pathways Announces Pricing of Underwritten Offering

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Dec 18, 2024, 6:30 AM EST - 6 months ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Compass Pathways to Participate in December Investor Conferences

Nov 25, 2024, 4:00 PM EST - 7 months ago

Compass Pathways to Participate in December Investor Conferences

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Nov 14, 2024, 7:44 AM EST - 8 months ago

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Top 3 Health Care Stocks You'll Regret Missing In November

Nov 5, 2024, 6:58 AM EST - 8 months ago

Top 3 Health Care Stocks You'll Regret Missing In November

PACS SGHT

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Nov 1, 2024, 5:10 PM EDT - 8 months ago

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 2:49 PM EDT - 8 months ago

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Oct 31, 2024, 6:30 AM EDT - 8 months ago

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Oct 24, 2024, 6:30 AM EDT - 8 months ago

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Sep 23, 2024, 7:00 AM EDT - 9 months ago

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Compass Pathways to participate in three investor conferences in September

Aug 28, 2024, 6:00 AM EDT - 10 months ago

Compass Pathways to participate in three investor conferences in September

Psychedelic Stocks: Focus On Their Cash

Aug 15, 2024, 12:30 PM EDT - 11 months ago

Psychedelic Stocks: Focus On Their Cash

MNMD

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Aug 12, 2024, 12:12 PM EDT - 11 months ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CYBN MNMD

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Aug 4, 2024, 1:22 AM EDT - 11 months ago

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Compass Pathways announces second quarter 2024 financial results and business highlights

Aug 1, 2024, 6:30 AM EDT - 11 months ago

Compass Pathways announces second quarter 2024 financial results and business highlights

Compass Pathways to announce second quarter financial results on August 1, 2024

Jul 24, 2024, 7:01 AM EDT - 1 year ago

Compass Pathways to announce second quarter financial results on August 1, 2024

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jul 8, 2024, 10:11 AM EDT - 1 year ago

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

Jun 26, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Jun 24, 2024, 4:01 PM EDT - 1 year ago

Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

May 23, 2024, 12:15 PM EDT - 1 year ago

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

MNMD

COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript

May 11, 2024, 5:31 PM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

May 8, 2024, 6:45 AM EDT - 1 year ago

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

May 8, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Compass Pathways to announce first quarter financial results on May 8, 2024

May 3, 2024, 4:58 PM EDT - 1 year ago

Compass Pathways to announce first quarter financial results on May 8, 2024

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

May 2, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

Apr 29, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference

Apr 1, 2024, 4:01 PM EDT - 1 year ago

Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference

diodor
diodor Jun. 27 at 9:18 AM
$CMPS
0 · Reply
No_one_important_in_here
No_one_important_in_here Jun. 27 at 12:27 AM
$ALT what is it with bios presenting what looks like good data and they get cut in half? Same thing happened to $CMPS. Market must hate good news lately 😏
2 · Reply
No_one_important_in_here
No_one_important_in_here Jun. 26 at 9:15 PM
$CMPS soon...
0 · Reply
cacci11
cacci11 Jun. 26 at 7:51 PM
$CMPS after hours pump incoming
2 · Reply
Bulltrader988
Bulltrader988 Jun. 26 at 7:12 PM
$MNMD added this basket today $CMPS $CYBN $MIRA 👃👀
0 · Reply
InvestorNOR
InvestorNOR Jun. 26 at 6:19 PM
$CMPS $3 is imminent 🙏
0 · Reply
dboyer_32
dboyer_32 Jun. 26 at 5:08 PM
$CMPS
0 · Reply
SlayQueenOfCalls
SlayQueenOfCalls Jun. 26 at 4:59 PM
$CMPS 🎵🎵 don’t shroom me like that, don’t shroom me like that, what if I love you baby? Don’t shroom me like that. 🎶🎶
1 · Reply
cacci11
cacci11 Jun. 26 at 4:52 PM
$CMPS lame duck volume by comparison, but still movement. Price action is depressing, but shorts die hard
1 · Reply
No_one_important_in_here
No_one_important_in_here Jun. 26 at 4:44 PM
$CMPS this shade of green isnt what i like. Give us the shade of green that we had yesterday :)
0 · Reply
cacci11
cacci11 Jun. 26 at 4:43 PM
$ATAI $CMPS $CYBN whole sector is asleep at the wheel
0 · Reply
GreenerPastures
GreenerPastures Jun. 26 at 4:11 PM
$CMPS ...does this make run for a quicky new low just for good measure...??...wanting to buy more but lower if possible...wouldn't surprise if it grinds down to induce nervous nellies to give up...maybe not because to many know and then too many retail would buy too many on the cheap...maybe better buy now...??...too much guessing in this business... anyone have valid thoughts on which between mnmd cybn atai or cmps will have meds on the market first and which holds most promise overall...???
3 · Reply
BStubbs
BStubbs Jun. 26 at 3:57 PM
$CMPS to me this is a huge buying opportunity!
0 · Reply
theflynews
theflynews Jun. 26 at 3:55 PM
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial - $CMPS - https://thefly.com/permalinks/entry.php/CMPSid4150944?17
0 · Reply
SlayQueenOfCalls
SlayQueenOfCalls Jun. 26 at 3:43 PM
$BFLY so I’m not a medical device nor pharma person (except $CMPS & $ELDN) - here are my positions and idk why but I like them. I love the product. I don’t think there are too many of us here.. are there?
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Jun. 26 at 3:00 PM
$CMPS I find it odd or coincidence that RFK MAKES THESE STATEMENTS BEFORE CONGRESS ON THE SAME WEEK - **A DAY AFTER** CMPS GIVES PHASE 3 RESULTS THAT WERE MEDICALLY SIGNIFICANT. 3.6 vs 5 expected from baseline.
1 · Reply
macrossluvsrobotech
macrossluvsrobotech Jun. 26 at 2:48 PM
$CMPS "Psychedelic therapies show real promise for veterans and others battling trauma. We're accelerating clinical trials at @US_FDA with urgency-and working to ensure safe, science-based access within 12 months. Some therapies can't wait."
1 · Reply
macrossluvsrobotech
macrossluvsrobotech Jun. 26 at 2:47 PM
$CMPS -3.6 vs -5 what the market wanted is so stupid. FDA will greenlight this so fast with Robert Kennedy at the helm. SIGNIFICANT IMPROVEMENT. BASICALLY -4 points. BY ONE POINT THE MARKET DUMPS. Buy thy dips.
0 · Reply
Cheaslea76
Cheaslea76 Jun. 26 at 2:30 PM
$CMPS in 2.61
0 · Reply
Bowlofpasta
Bowlofpasta Jun. 26 at 2:16 PM
$CMPS in
0 · Reply
Stoneape
Stoneape Jun. 26 at 1:56 PM
$CMPS We need heavy buying at this dip.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Jun. 26 at 1:45 PM
$CMPS Study showed ZERO negative effects. You have to be blind not to load when people sell this to you at discount. This continue to climb, not fall on results affirming nearly 4 points out of 5 expected. Long.
0 · Reply